Global Breast Cancer Predictive Genetic Testing Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Breast Cancer Predictive Genetic Testing Revenue
• 1.4 Market by Type
  • 1.4.1 Global Breast Cancer Predictive Genetic Testing Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 High Penetrant Genes
  • 1.4.3 Intermediate Penetrant Genes
  • 1.4.4 Low Penetrant Genes
• 1.5 Market by Application
  • 1.5.1 Global Breast Cancer Predictive Genetic Testing Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Clinics
  • 1.5.4 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Breast Cancer Predictive Genetic Testing Market Perspective (2015-2026)
• 2.2 Global Breast Cancer Predictive Genetic Testing Growth Trends by Regions
  • 2.2.1 Breast Cancer Predictive Genetic Testing Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Breast Cancer Predictive Genetic Testing Historic Market Share by Regions (2015-2020)
  • 2.2.3 Breast Cancer Predictive Genetic Testing Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Breast Cancer Predictive Genetic Testing Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Breast Cancer Predictive Genetic Testing Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Breast Cancer Predictive Genetic Testing Players by Market Size
  • 3.1.1 Global Top Breast Cancer Predictive Genetic Testing Players by Revenue (2015-2020)
  • 3.1.2 Global Breast Cancer Predictive Genetic Testing Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Breast Cancer Predictive Genetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Breast Cancer Predictive Genetic Testing Market Concentration Ratio
  • 3.2.1 Global Breast Cancer Predictive Genetic Testing Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Breast Cancer Predictive Genetic Testing Revenue in 2019
• 3.3 Breast Cancer Predictive Genetic Testing Key Players Head office and Area Served
• 3.4 Key Players Breast Cancer Predictive Genetic Testing Product Solution and Service
• 3.5 Date of Enter into Breast Cancer Predictive Genetic Testing Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Breast Cancer Predictive Genetic Testing Historic Market Size by Type (2015-2020)
• 4.2 Global Breast Cancer Predictive Genetic Testing Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Breast Cancer Predictive Genetic Testing Market Size by Application (2015-2020)
• 5.2 Global Breast Cancer Predictive Genetic Testing Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Breast Cancer Predictive Genetic Testing Market Size (2015-2020)
• 6.2 Breast Cancer Predictive Genetic Testing Key Players in North America (2019-2020)
• 6.3 North America Breast Cancer Predictive Genetic Testing Market Size by Type (2015-2020)
• 6.4 North America Breast Cancer Predictive Genetic Testing Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Breast Cancer Predictive Genetic Testing Market Size (2015-2020)
• 7.2 Breast Cancer Predictive Genetic Testing Key Players in Europe (2019-2020)
• 7.3 Europe Breast Cancer Predictive Genetic Testing Market Size by Type (2015-2020)
• 7.4 Europe Breast Cancer Predictive Genetic Testing Market Size by Application (2015-2020)

8 China

• 8.1 China Breast Cancer Predictive Genetic Testing Market Size (2015-2020)
• 8.2 Breast Cancer Predictive Genetic Testing Key Players in China (2019-2020)
• 8.3 China Breast Cancer Predictive Genetic Testing Market Size by Type (2015-2020)
• 8.4 China Breast Cancer Predictive Genetic Testing Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Breast Cancer Predictive Genetic Testing Market Size (2015-2020)
• 9.2 Breast Cancer Predictive Genetic Testing Key Players in Japan (2019-2020)
• 9.3 Japan Breast Cancer Predictive Genetic Testing Market Size by Type (2015-2020)
• 9.4 Japan Breast Cancer Predictive Genetic Testing Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Breast Cancer Predictive Genetic Testing Market Size (2015-2020)
• 10.2 Breast Cancer Predictive Genetic Testing Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Breast Cancer Predictive Genetic Testing Market Size by Type (2015-2020)
• 10.4 Southeast Asia Breast Cancer Predictive Genetic Testing Market Size by Application (2015-2020)

11 India

• 11.1 India Breast Cancer Predictive Genetic Testing Market Size (2015-2020)
• 11.2 Breast Cancer Predictive Genetic Testing Key Players in India (2019-2020)
• 11.3 India Breast Cancer Predictive Genetic Testing Market Size by Type (2015-2020)
• 11.4 India Breast Cancer Predictive Genetic Testing Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Breast Cancer Predictive Genetic Testing Market Size (2015-2020)
• 12.2 Breast Cancer Predictive Genetic Testing Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Breast Cancer Predictive Genetic Testing Market Size by Type (2015-2020)
• 12.4 Central & South America Breast Cancer Predictive Genetic Testing Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Roche
  • 13.1.1 Roche Company Details
  • 13.1.2 Roche Business Overview
  • 13.1.3 Roche Breast Cancer Predictive Genetic Testing Introduction
  • 13.1.4 Roche Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020))
  • 13.1.5 Roche Recent Development
• 13.2 Thermo Fisher Scientific
  • 13.2.1 Thermo Fisher Scientific Company Details
  • 13.2.2 Thermo Fisher Scientific Business Overview
  • 13.2.3 Thermo Fisher Scientific Breast Cancer Predictive Genetic Testing Introduction
  • 13.2.4 Thermo Fisher Scientific Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020)
  • 13.2.5 Thermo Fisher Scientific Recent Development
• 13.3 PerkinElmer
  • 13.3.1 PerkinElmer Company Details
  • 13.3.2 PerkinElmer Business Overview
  • 13.3.3 PerkinElmer Breast Cancer Predictive Genetic Testing Introduction
  • 13.3.4 PerkinElmer Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020)
  • 13.3.5 PerkinElmer Recent Development
• 13.4 Quest Diagnostics
  • 13.4.1 Quest Diagnostics Company Details
  • 13.4.2 Quest Diagnostics Business Overview
  • 13.4.3 Quest Diagnostics Breast Cancer Predictive Genetic Testing Introduction
  • 13.4.4 Quest Diagnostics Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020)
  • 13.4.5 Quest Diagnostics Recent Development
• 13.5 Myriad Genetics
  • 13.5.1 Myriad Genetics Company Details
  • 13.5.2 Myriad Genetics Business Overview
  • 13.5.3 Myriad Genetics Breast Cancer Predictive Genetic Testing Introduction
  • 13.5.4 Myriad Genetics Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020)
  • 13.5.5 Myriad Genetics Recent Development
• 13.6 Iverson Genetics
  • 13.6.1 Iverson Genetics Company Details
  • 13.6.2 Iverson Genetics Business Overview
  • 13.6.3 Iverson Genetics Breast Cancer Predictive Genetic Testing Introduction
  • 13.6.4 Iverson Genetics Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020)
  • 13.6.5 Iverson Genetics Recent Development
• 13.7 Cancer Genetics
  • 13.7.1 Cancer Genetics Company Details
  • 13.7.2 Cancer Genetics Business Overview
  • 13.7.3 Cancer Genetics Breast Cancer Predictive Genetic Testing Introduction
  • 13.7.4 Cancer Genetics Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020)
  • 13.7.5 Cancer Genetics Recent Development
• 13.8 OncoCyte Corporation
  • 13.8.1 OncoCyte Corporation Company Details
  • 13.8.2 OncoCyte Corporation Business Overview
  • 13.8.3 OncoCyte Corporation Breast Cancer Predictive Genetic Testing Introduction
  • 13.8.4 OncoCyte Corporation Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020)
  • 13.8.5 OncoCyte Corporation Recent Development
• 13.9 NeoGenomics
  • 13.9.1 NeoGenomics Company Details
  • 13.9.2 NeoGenomics Business Overview
  • 13.9.3 NeoGenomics Breast Cancer Predictive Genetic Testing Introduction
  • 13.9.4 NeoGenomics Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020)
  • 13.9.5 NeoGenomics Recent Development
• 13.10 Invitae
  • 13.10.1 Invitae Company Details
  • 13.10.2 Invitae Business Overview
  • 13.10.3 Invitae Breast Cancer Predictive Genetic Testing Introduction
  • 13.10.4 Invitae Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020)
  • 13.10.5 Invitae Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer